Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

Glenn Deng, Michael Herrler, David Burgess, Edward Manna, David Krag and Julian F Burke*

Breast Cancer Research 2008, 10:R69 doi:10.1186/bcr2131

Accesses  

  • Last 30 days: 99 accesses
  • Last 365 days: 1435 accesses
  • All time: 6672 accesses

Cited by